IT0005274094
IT0005274094
PHARMANUTRA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 132.939.000 | 116.788.000 | 13.8% |
| Cost of Revenue | 30.071.000 | 25.968.000 | 15.8% |
| Gross Profit | 102.868.000 | 90.820.000 | 13.3% |
| 72.598.000 | 62.726.000 | 15.7% | |
| Operating Income | 30.270.000 | 28.094.000 | 7.7% |
| Pretax Income | 30.189.000 | 27.161.000 | 11.1% |
| Net Income Common Stockholders | 20.002.000 | 16.608.000 | 20.4% |
| -- | -- | -- | |
| -- | -- | -- |